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Two recent developments  have stimulated renewed interest in E,  scherichia 
coli infections of man. In the first place, through the important investigations 
of Kauffmann and his associates  (1,  2) extensive knowledge has been gained 
on  the  antigenic  pattern  of  this  species. The  discovery  by Kauffmann of 
antigens as inhibitors of O agglutinability and the identification of the various 
antigens (the somatic  O antigens,  the envelope or surface L and B antigens, 
the capsular  A antigens,  and the flagellar H antigens)  have brought order to 
the serological grouping and typing of E. coli and made possible studies on the 
relationship between antigenic types of E. coli and various infections. 
The second discovery of major importance is the finding of the association 
of two serological groups  of E.  coli,  namely, serogroups Olll and 055, with 
epidemic and sporadic diarrheal disease of infants. In 1923 and 1927, Adam 
(3, 4)  reported on the recovery of several biochemical  types of E.  coli  from 
patients  with  diarrheal  disease.  It  remained  for  the  British  investigators 
Bray (5), Bray and Beavan (6), Giles and Sangster  (7), Giles, Sangster,  and 
Smith (8), Smith  (9), as well as Taylor, Powell, and Wright (10) to establish 
the fact that in certain outbreaks of epidemic  diarrhea two  serogroups  of 
E.  coli  are found in a high percentage  of affected children  and 0nly rarely in 
healthy infants, children,  and adults. These  two antigenic  groups have been 
identified  as serogroups Olll and 055.  The observations  of these investiga- 
tors have been confirmed and extended in various parts of the world, including 
the Scandinavian countries by Kauffmann and Dupont (11), the Netherlands 
by  Beeuwkes,  Hodenpijl,  and  ten  Seldam  (12), Germany by  Braun  (13), 
and  the  United  States  by Modica,  Ferguson,  and  Ducey  (14), Neter  and 
Shumway (15), Neter and Webb  (16), Neter, Webb,  Shumway, and Murdock 
(17). Very recently, Orskov (18) reported on the occurrence of E. coli belong- 
ing to O-group 26 in cases of infantile diarrhea and in white scours of newborn 
calves. Thus it appears  likely that groups other than Olll and 055  may be 
associated with diarrheal disease of infants. 
* Supported in part by grants from Lederle Laboratories Division, American Cyanamid 
Company, Pearl River, BI. Y. and Ciba Pharmaceutical  Products, Inc., Summit,  N. J. 
1 HEMAGGLUTINATION AND ]~ZEMOLYSIS BY  ESCttERICItIA  COLI 
It  is  an established  fact  that  certain  bacterial  antigens may  be  adsorbed 
on red blood cells, thus rendering these erythrocytes specifically agglutinable 
by the  homologous  bacterial  antiserum.  Recently,  it  was  shown  by  Neter, 
Bertram,  and Arbesman (19)  that  the group-specific antigens of E.  coli Olll 
and  055  can  be  demonstrated  by  means  of  such  a  hemagglutination  test. 
The  experiments  to  be  reported  in this  communication were  undertaken  to 
study this hemagglutination test  in greater  detail,  to  determine whether  the 
antigens can be demonstrated  also by means of a  hemolysis test,  to  compare 
the  sensitivity  of  bacterial  agglutination,  hemagglutination,  and  hemolysis 
tests  for  the  demonstration of E.  coli  antibodies,  and  to  ascertain  whether 
the  antigens  can  be  assayed  by  means  of  hemagglutination  and  hemolysis 
inhibition tests. 
Material and Methods 
Several strains of F.. coil of serogroups  055 and Ol11, isolated from infants suffering from 
diarrheal disease,  were used. The microorganisms were  maintained on brain-veal-agar and 
transferred weekly.  Each subculture was checked by means of group-specific  antisera. For 
the experiments proper the strains were grown in brain-heart infusion and on brain-veal- 
agar (Kolle flasks).  The broth cultures were incubated for 3 to 5 days at 37°C. and passed 
through a  Seitz (EK No. 5) filter after the pH had been adjusted to 7. The filtrates were 
tested for sterility and kept in the refrigerator. The microorganisms grown on brain-veal-agar 
in a Kolle flask for 24 hours at 37°C. were suspended in 25 ml. of physiological saline solution. 
Unless otherwise  indicated, both broth culture filtrates and agar suspensions were boiled for 
2 hours. 
Separation of bacterial cells from the surrounding fluid was accomplished  by means of a 
refrigerated centrifuge (International, model P  R-l; r.c.f,  at tip of tube calibrated to be 
24,000;  centrifugalization for from 10 to 90 minutes). The sediment was resuspended in an 
equal amount of physiological saline solution. 
Red blood cell suspensions (2.5 per cent) in physiological saline solution were  prepared 
from oxalated or defibrinated blood of man and various animal species. The blood was washed 
in physiological saline solution prior to use. 
Red blood cells were modified in the following manner. To the sediment of the red blood 
cell suspension was added E. ¢oU antigen to make a 2.5 per cent suspension. The mixtures 
were kept in 15 ml. centrifuge tubes at 37°C. for 1 hour and mixed repeatedly. The cells were 
then washed three times in physiological saline solution and made up to a 2.5 per cent sus- 
pension. 
The following  E. coU antisera were  employed: (a)  serum from rabbits immunized with 
both boiled and unheated suspensions of the two serogroups; such sera contain both O and 
B  antibodies; (b)  serum from rabbits immunized with boiled suspensions; these  antisera 
contain O antibodies; (c) for control purposes, antisera containing both O and B antibodies, 
made available through the kindness of Dr. William H. Ewing of the Communicable Disease 
Center, Chamblee, Ca. All sera were  tested for specificity in the bacterial agglutination test. 
The modified cells (volume 0.2 ml.) were then added to 0.2 ml. of various E. coli antisera 
in serial dilutions. The mixtures were incubated at 37°C. and agglutination was read in the 
gross at intervals up to 2 hours. Following the last reading the tubes were  centrifuged at 
2,000 R.P.~. for 1 minute and again read. In the hemolysis experiments complement (0.1 ml. 
of a  1: l0 diluted guinea pig serum) was added to the antiserum prior to the addition of the NETER,  BERTRAM, ZAK, ZfURDOCK~ AND ARBESMAN 
modified red cells. The complement was procured from Carworth Farms, Inc., New City, 
N. Y. Hemolysis was read in the gross after incubation at 37°C. at intervals up to 2 hours. 
In the hemagglutination and hemolysis inhibition tests E. coli antiserum was mixed with 
E. coli antigens in various concentrations and incubated for 30 minutes at 37°C.; then, modi- 
fied red blood cells were added. The mixtures were incubated and read as described above. 
In the hemolysis inhibition tests complement was either present during the first phase of the 
experiment or added just prior to the admixture of the E. coU-treated r~d blood cells. 
These hemagglutination, hemolysis,  hemagglutination inhibition, and hemolysis  inhibi- 
tion tests are based on the techniques developed during studies with other bacterial antigens 
by Keogh and associates (20, 21), Middlebrook and Dubos (22), Hayes and Stanley (23), 
Hayes (24), as well as Wright and Feinberg (25). 
TABLE I 
Agglutination of Red Blood Cells of Various Species Treated with E. coli 0111 Antigen 
Anti-E. coU serum 
)111  1:100 
1:200 
1:400 
1:800 
1:1600 
0 
)55*  1:100 
Man 
4 
4 
3 
Dog 
4 
4 
4 
Rabbit 
4 
3 
3 
4- 
Sheep  pig 
4  4  4 
4  4  4 
4  3  3 
Guinea  Rat  Chicken 
4 
4 
3 
4- 
--  =  no agglutination. 
1 to 4 =  various degrees of agglutination. 
* This serum agglutinated in dilutions up to 1:800 red blood cells treated with E. coli 
055 antigen. 
RESUT..TS 
Modificalion  of Red Blood  Cells  of Different  Species  by  E.  coli  Antigens.- 
It  was  previously shown  (19)  that  red  blood  cells of  both  man  and  rabbit 
adsorb E.  coli Olll  and  055  antigens and  thus become agglutinable by the 
homologous  group-specific antisera;  only  the  boiled,  but  not  the  unheated, 
E. coli suspensions and broth culture filtrates  were found to be highly active. 
It  was  considered of interest  to  determine whether  red  blood  cells of other 
species could be modified in like manner.  To this end,  washed blood cells of 
dog,  guinea pig,  sheep,  chicken,  and  rat,  in addition to  cells from man  and 
rabbit, were utilized. The results of a  representative experiment with E.  coli 
Olll  antigen  (boiled  broth  culture  filtrate)  after  incubation  for  1  hour  at 
37°C.  and centrlfugalization are summarized in Table I.  It can be seen that 
blood  cells from  all  species  adsorbed  the  antigen  and  that  the  tiler  of  the 
antiserum was roughly identical with all modified red blood cell suspensions. 
Antisera containing either  Olll  antibodies  or  both  Olll  and  B  antibodies 4  IIEMAGGLUTINATION AND  IIEMOLYSIS  BY  ESCHERIC]KI.A-COLI 
were  effective.  The  specificity of  this  hemagglutination  reaction  is  evident 
from the fact that E. coli 055  antiserum in like dilutions failed to agglutinate 
Olll-treated  red  blood  cells,  although  this  serum  strongly  agglutinated red 
blood cells treated with E. coli 055  antigen. 
Titration  of E.  coli Antigen and the Effect of Time on Its Adsorption  by Red 
Blood  Cells.--Nfimerous  experiments were  carried out  in  order  to  determine 
quantitatively the activity of various E.  coli antigens in modifying red blood 
TABLE II 
Titration of E. coli Antigen and the Effect of Time on the Adsorption of This Antigen on Red 
Blood Cells 
Anti-E. toll serum 
0111  1:100 
1:200 
1:400 
1:  800 
1:1600 
1:  3200 
0 
055*  1:100 
E. ¢oli 0111 antigen diluted 
and acting on red blood ceils for 
-4  4  4  T  3  i  4  I  --T--  1 
--  !  i  --  --  -- 
4  -!-!-  -  - 
-  -_  -  2  -  _ 
--  -----  no agglutination. 
1 to 4 =  various degrees of agglutination. 
* This serum agglutinated in dilutions up to  1:800  red blood cells treated with E. coli 
055 antigen. 
cells and to ascertain the effects of time  on their adsorption. A  typical experi- 
ment is presented in Table II. 
A suspension in physiological saline solution of E. coli O I I I, harvested from brain-veal-agar 
and boiled for 2 hours, served as antigen. This antigen was used in dilutions of 1:5,  1:25, 
and  1:50 for treatment of human red blood cells for 5,  15, and 30 minutes, respectively. 
The agglutination of the modified red blood cells by the homologous E. co//antiserum in 
serial dilutions after incubation for  I  hour at 37°C. and  centrifugallzation is recorded  in 
Table II. 
Perusal  of this table shows that  the  modification of the red blood cells by 
the  more  concentrated antigen  occurs rather  rapidly  and  increases but  little 
following incubation  for  more  than  5  minutes.  On  the  other  hand,  red  cells 
treated with the  more diluted antigen are rendered  more agglutinable follow- 
hag  prolonged  treatment.  Thus,  it  is  evident  that  the  antigen modification NET'ER~ BERTRAM, ZAK, MURDOCK, AND ARBESMAN 
of red blood cells is a  function of the  activity or  concentration of the antigen 
and of time. 
The  Relationship  between  Concentration  of  E.  coli  Antigen  and  Number  of 
Red Cells, and  the Adsorption  of the Antigen.--It  seemed  to  be  of  interest  to 
determine whether the adsorption of E.  coli antigen and the  resulting hemag- 
glutination by E.  coli  antiserum depend  also upon  the  number  of red blood 
cells treated.  To  this end,  the following experiment was carried out. 
TABLE III 
The Relationship  between Concentration of E.  coli Antigen  and  Number  of Red Blood Cells, 
and the Adsorption  of the A ntigen and Resulting Hemagglutlnation 
Red blood  cells  from whole  blood,  ral. 
E. coli  O111antiserum  0"210'210"210"210"61  1:8 
treated with E. coli  0111 antigen (2 ml.) in dilutions  of 
1:5  1:135  1:5  1:$ 
1:100 
1:200 
1:400 
1:800 
1:1600 
1:3200 
1:6400 
0 
4 
4 
4 
4 
3 
1 
1:15 
4 
4 
4 
4 
3 
1:45  ! __ 
m 
m 
4 
4 
4 
1 
R.  coli antigen (a suspension  procured from brain-veabagar and boiled for  2  hours)  in 
dilutions of 1: 5, 1:15, 1: 45, and 1:135 (volume 2 ml.) was used for the treatment of red blood 
cells from 0.2 ml. of oxalated human blood. In addition, the antigen in a  dilution of 1:5 
(volume 2 ml.) was used for the treatment of red blood ceils from 0.6 ml. and 1.8 nil. of the 
same blood specimen. The red blood cells were treated with this antigen for 1 hour at 37°C., 
washed three times in physiological  saline solution,  and suspended  to give a 2.5 per cent red 
blood ceil suspension. These blood ceil suspensions were  then used as modified antigen and 
mixed with E. ¢oli Olll antiserum in  serial dilutions and  055  antiserum as control. The 
resulting hemagglutinati0n, read after incubation at 37°C. for 1 hour and centrifugalization, 
as recorded in Table HI. 
A  perusal of this table shows that the more red cells were treated with the 
antigen  in  identical  concentration  the  less  agglutination  occurred  with  the 
homologous  E.  coli  antiserum.  It  is  thus  evident  that  the  antigenic  modi- 
fication of red blood cells by  E.  coli  antigen and the resulting hemagglutina- 
tion  by  the  homologous  E.  coli  antiserum  depend  upon  the  concentration 
of  the  red  blood  cells  and,  as  shown  above,  upon  the  concentration  of  the 
antigen and the time of treatment. 
Simultaneous  Adsorption  of  Two  E.  coli  Antigens  by  Red  Blood  Cdls.--In HEM.AGGLUTINATION  AND  HEMOLYSIS  BY  ESCHERICHIA  COLI 
order  to  ascertain  whether  red  blood  cells  adsorb  the  two  different  E.  coli 
antigens  under  consideration,  the  following experiment  was  carried  out. 
Human red blood cells were treated for 1 hour at 37°C. with (a) 2 ml. of a  1:5 diluted 
E. coli Olll agar suspension which had been boiled for 2 hours, (b) 2 ml. of the corresponding 
055 g. coli antigen,  and  (c) a mixture  of both antigens  in equal amounts.  These antigen- 
modified cells were then tested with both g. coli Ol11 and E. coli 055 antisera in serial dilu- 
tions. The results of this experiment after incubation for 1 hour at 37°C. and centrifugaliza- 
tion are presented in Table IV. 
It can be noted that  the red blood cells treated  with  the two antigens  be- 
came  agglutinable  by both  antisera.  It  should  be  pointed  out that  each  an- 
TABLE IV 
Simultaneous  Adsorption  by Red Blood Cells of Two Different E. coil Antigens 
E. coli antlsera 
0111 
055 
1:100 
1:200 
1:400 
1:800 
1:1600 
0 
1:100 
1:200 
1:400 
1:800 
Agglutination by E. coU antlsera of red blood ceils treated with E. ¢oli 
055 antigen 
m 
m 
4 
3 
0111 antigen 
4 
4 
4 
4 
m 
m 
055 and O111 antigcms 
4 
4 
4 
4 
4 
--  =  no agglutination. 
1 to 4 ffi various degrees of agglutination. 
tiserum  caused  complete  hemagglutination,  as  all  red  cells  became  agglu- 
tinated  in  one  solid  clump  and  unagglutinated  red  cells were  not  present. 
This  observation,  which  was  made  in  repeated  experiments,  suggests  that 
a11 the red cells had  adsorbed both antigens rather  than  that half of the red 
cells had  adsorbed  one antigen  and  the  other  half  the  other.  Proof that  red 
cells  are  capable,  indeed,  of adsorbing  both  E.  coli  antigens  is  furnished  by 
the results  of the following experiment.  Human blood cells were treated  with 
Olll  antigen in one series,  with 055  antigen in the second,  and with a  mix- 
ture  of both  antigens  in  the  third.  An  equal  mixture  of  Olll-treated  cells 
and  O55-treated  cells  was  then  prepared.  All  cell  suspensions  were  tested 
with  Olll  and 055  antisera.  It was found that  both antisem produced ouly 
partial  agglutination  of  the  mixture  of  Ol11-  and  O55-treated  cells  but 
agglutinated  completely the red cells treated either with the homologous anti- NETER~ BERTRAM~ ZAK~ MURDOCK~ AND ARBESMAN  7 
gen or a mixture of both antigens. The same results were obtained when Olll- 
treated  cells  were  mixed  with  untreated  cells  and  then  tested  with  0111 
antiserum. It is concluded, therefore, that  each red cell adsorbs both antigens. 
The  Effects  of Subsequent  Treatments  of Red  Blood  Cells  with  Different  E. 
coli  Antigens.--It  is  conceivable that  the  adsorption  of  one  E.  coli  antigen 
renders  the  blood  cells  incapable  of subsequently  adsorbing  another  E.  coli 
antigen.  To test  this  hypothesis,  a  large number of experiments  were carried 
TABLE V 
The Effects of Subsequent Treatments of Red Blood Cells u,  ith Different E. coli Antigens on 
the Adsorption of These Antigens 
E. coh~'~tlsera 
Olll  1:100 
1:200 
1:400 
1:800 
1:1600 
1:3200 
0 
055  1:100 
1:200 
1:400 
1:800 
1:1600 
Agglutination  of red blood cells by E. cob antisera after 
treatment with E. coli antigens 
055 
-  4 
-  4 
-  4 
-  3 
-  2 
-  -4- 
4 
2 
2 
m 
O111  0111 followed 
by 055 
4 
4 
4 
3 
-4- 
m 
4 
4 
1 
055 followed 
by O111 
4 
4 
4 
4 
2 
4 
3 
2 
out  in  which  the  two  E.  coli  antigens  under  consideration  were  used  con- 
secutively rather than simultaneously. 
Red cells were treated with one E. coli antigen,  washed three  times, and then treated 
with the other,  followed by washing. For control purposes red cells were treated with one 
antigen alone and incubated  and washed in like fashion. The results of a typical experiment 
are given in Table V. 
It can be noted that red cells  treated  with Olll  antigen later  adsorb 055 
antigen  and  vice  versa.  This  consecutive  treatment  with  two  antigens  re- 
suited  in hemagglutination  by both antisera  in essentially identical  dilutions. 
It is conceivable that under different conditions blocking of one antigen may 
result  from previous  treatment  with  another.  Thus  far,  this  had  not  been 
observed.  In  this  connection  it  can  be  noted  that  human  red  ceils  which 
had  adsorbed  either  one  or both  E.  coli  antigens  were  agglutinated  readily 
by  blood  group-specific  and  Rh-specific  antibodies,  indicating  that  the  E. 8  HEMAGGLUTINATION  AND  HEMOLYSIS  BY  ESCHERICHIA. COLI 
coli  antigens  did not  block the  A,  B,  or Rh  antigens  of red  blood cells and 
prevent  agglutination  by  the  homologous  blood  group-specific  antibodies. 
Hemolysis by E. coli Antisera.--Experiments  were carried out to determine 
whether red blood cells modified by E. coli antigens can be lysed in the pres- 
ence  of  E.  coli  antibodies  and  complement.  Numerous  experiments  yielded 
identical results. 
Human red blood cells (blood group O) and sheep cells were treated for 1 hour at 37°C. 
with a 1 : 5 diluted E. eoli O 111 brain-veal-agar  suspension, which had been previously  boiled for 
2 hours. The washed red blood cell suspensions were then mixed with four different E. coli 
antisera (sera containing either O antibodies only or O and B antibodies) and normal rabbit 
TABLE VI 
Hcmagglutination and Hemolysis by E: coli 0111 Antiserum  of Human and Sheep Red Blood 
Cells Treated with E. coli 0111 Antigen 
Antisera containing antibodies to 
antigens 
Titer of E. coli antisera causing 
Hemagglutination of cells  Hemolysis of cells treated  Bacterial 
treated with O111 antigen  with O111 antigen  agglutination  of boiled 
bacterial 
Human cells  Sheep cells  suspension 
1:1600 
1:1600 
1:1600 
1:1600 
Olll 
Olll -k B 
055* 
055 -k B* 
Normal rabbit serum 
Human cells . Sheep cells 
1:4oo  k 1:51,2oo 
1:100  I 1:25,600 
--  1:800 
1: 200 
1:1500 
1:800 
2 
* This serum caused hemagglutination and hemolysis of red blood cells treated with 
E. coli 055 antigen. 
-- ffi no reaction with serum in dilutions of 1:100 and higher. 
serum in serial dilutions, in the absence of complement  in one series and in the presence of 
complement  (1:10 dilution) in the other. The same antisera were also tested for antibodies 
producing bacterial agglutination; the identical boiled bacterial suspensions, which were used 
for the modification of the red blood cells, were employed. The hemagglutination and hemoly- 
sis tests were read after incubation at 37°C. for 1 hour; the bacterial agglutination after 18 
hours at 56°C. The results are presented in Table VI. 
It can be noted that both E. coli Olll  antisera produced hemagglutination 
and  hemolysis  of  the  modified red  cells and  agglutination  of  the  bacteria. 
It is also evident that  the titer of these antisera producing sheep cell hemol- 
ysis is greater  by far than the titer producing sheep and  human  cell  hemag- 
glutination  and  bacterial  agglutination.  It  can  also  be  seen  that  the 
heterologous E.  coli  antisera failed to produce  agglutination of the bacteria, 
hemagglutination  and  hemolysis  of  human  cells,  and  hemagglutination  Of 
sheep  cells;  however,  these  sera  in  relatively low  titer  produced  sheep  cell 
hemolysis. This cross-reacting antibody, as demonstrated by sheep cell hemol- NETER~  BERTRAM~ ZAK~ MURDOCK~ AND  ARBESMAN 
ysis, represents  only a  small fraction of the titer of  antibodies  causing  lysis 
of sheep cells treated with the homologous antigen. A poorly developed cross- 
reaction between E.  coli 055  and Olll  has been  demonstrated previously 
by  Kauffmann (1). This  hemolysis  test  may offer  a  sensitive  method for 
further studies on the  cross-reaction  between  the two serogroups of E.  coll. 
Distribution  of E.  coli Antigens  Operative in  Hemagglutination  by  E.  coli 
Antiserum  between Bacterial  Cells and  Supernate.--The  distribution  of  the 
E.  coli antigens operative in hemagglutination between  bacterial  cells and 
supernate was investigated next. 
TABLE  VII 
Distribution  of E. coli Antigen Operative in Hemagglutination by E. coli Antiserum between 
Bacterial Cells and Supernate 
H. coli Oln  anti.rum 
1:100 
1:200 
1:400 
1:800 
1:1600 
1:3200 
0 
Agglutination of red cells  treated  with E. coil  O111 (suspension in 
physiological  saline  of organisms obtained from brain-veal-agar) 
Suspension 
after 2 hrs. 
at 100°C. 
Sediment of 
unheated 
suspension 
after  2 hrs. 
at IO0°C. 
4 
4 
3 
3 
2 
1 
Superaate 
of unheated 
suspension 
after 2 hrs. 
at 100"C. 
Sediment 
of boiled 
suspension 
3  ¸ 
2 
1 
Supernate 
of boiled 
suspension 
4 
4 
4 
3 
--  ~= no agglutination. 
1 to 4  =  various degrees of agglutination. 
A  suspension of E. coil 0111  from brain-veal-agar in physiological saline  solution was 
divided into  two portions; one portion was  separated  in  the refrigerated  centrifuge into 
sediment and supemate, the other was first boiled for 2 hours and then centrifugaiized. The 
sediments were resuspended in identical amounts of physiological saline solution. All unheated 
materials, which failed to modify red blood cells for hemagglutination, were boiled for 2 
hours. These materials were then used together with the boiled, unseparated suspension for 
modification of haman red blood cells. The results of this experiment are recorded in Table VII. 
It can be noted that separation of the boiled suspension yields both active 
sediment and supernate, although the supernate is somewhat  more effective 
in modifying red blood  cells than the sediment.  In contrast, when the un- 
boiled suspension was separated and the two materials were boiled separately, 
the sediment was highly active and the supernate completely inactive.  It is 
evident, then, that boiling of the bacterial suspensio  n  results  in the appear- 
ance of the modifying antigen in the supernate, either because of activation of 
the antigen itself or because of elimination of an inhibitor.  It is interesting to 10  HEMAGGLUTINATION  AND  HEMOLYSIS  BY  ESCHERICHIA  COLI 
note  that  in  the  hemagglutination  and  hemolysis  inhibition  tests,  described 
below, it was possible to demonstrate  antigen in the supernate  obtained from 
unheated suspensions. This finding indicates that either the antigen is capable 
of adsorbing the antibody without being able to modify red blood cells or that 
TABLE VIII 
Hemagglutination and Hemolysis Inhibition Tests 
E. ¢oli 0111 antiserum (1:100) mixed 
with  E. ¢oti  0111 antigen 
Unheated 
Heated 
1:10 
1:20 
1:40 
1:80 
1:160 
1:320 
1:640 
1:1280 
0 
1:10 
1:20 
1:40 
1:80 
1:160 
1:320 
1:640 
1:1280 
0 
Agglutination and hemolysis of sheep blood cells modified by 
E.  coli  0111 antigen by 0111  antiserum treated with serial 
dilutions of E. ¢oU 0111 antigen 
Hemagglutination  Hemolysis 
(a)  (b)  (a)  (b) 
m 
m 
B 
2 
2 
4 
B 
m 
m 
3 
3 
4 
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--  =  no agglutination  or hemol ram. 
1 to 4 == various degrees of agglutination  or hemolysis. 
(a)  =  read after 30 minutes at 37°C. 
(b) -  read after 1 hour at 37°C. 
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E. coli 0111 antigen  from brain-veal-agar  in both the unheated  and the boiled  state  in 
two  different  antigens  are  involved  in  hemagglutination  and  hemaggluti- 
nation inhibition tests.  Identical results were obtained in repeated experiments 
using both E. coli  0111  and 055  suspensions. 
Hemagglutination  and  Hemolysis  Inhibition  Tests.--Experiments  under- 
taken  to  determine  whether  the  E.  coli  antigens  under  discussion  inhibit 
hemagglutination  and hemolysis yielded interesting  results.  A  typicM experi- 
ment is described herewith. NETER, BERTRAM, ZAK, MqYRDOCK, AND ARBESMAN  11 
serial dilutions (volume 0.1 nil.) was mixed with E.  ¢oU Olll antiserum  in a dilution of 1:100 
(volume 0.2 ml.). These mixtures were prepared  in duplicate;  one set for hemagglutination 
and the other for hemolysis; to each tube of the second set was added 0.1 ml. of a 1:10 diluted 
guinea pig serum (complement). All mixtures were kept for 30 minutes at 37°C. Then, to all 
tubes 0.2 ml. of 2½ per cent sheep cell suspension previously treated with E. coli  Olll antigen 
(boiled  agar suspension,  diluted  1:5)  was added.  The resulting  hemagglutination  (read 
after incubation for 1 hour at 37°C. and centrffugalization)  and hemolysis (read after 1 hour 
at 37°C.) are recorded in Table VIII. 
Perusal  of this  table  indicates  that  both  the  unheated  and  boiled E. coli 
antigens prevented hemagglutination and hemolysis. That the degree of hemol- 
ysis  inhibition  is  of  a  lower  order  of  magnitude  than  inhibition  of  hemag- 
glutination  is  readily  explained  by the  fact  that  E.  coli  antiserum  is  active 
in  far  higher  dilutions  in producing  sheep  cell  hemolysis  than  hemaggluti- 
nation.  It  is  of considerable  interest  to  point out that the unheated E.  coli 
suspensions,  which  do  not  modify red  blood  cells  for hemagglutination,  are 
highly  active  in  the  hemagglutination  and  hemolysis  inhibition  tests,  al- 
though  somewhat  less  so  than  the  boiled  antigens.  These  results  were  con- 
firmed  in  repeated  experiments;  with  some  antigens  the  boiled  suspensions 
were  considerably  more  active  than  the  unheated  ones. 
Red  Blood  Cells  Modified  by E.  coli  Antigen  as  Immunizing  Agent.--The 
antigens of E.  coli  serogroups 055  and Olll  adsorbed  on red blood cells act 
as antigens in ~ivo, as shown in the following experiment. 
Six rabbits, whose sera in a dilution  of 1:10 failed to agglutinate modified rabbit blood 
cells used in the hemaggiutination  test, were injected intravenously with 5 ml. each of a 
2t per cent suspension of rabbit red blood cells which had been treated with a 1:5 diluted, 
boiled brain veal agar suspension of R. coli  O111 and 055, respectively. Three such injectiotm 
were given 3 days apart and the rabbits were bled 8 days after the last injection. 
The  rabbits  developed  group-specific  E.  coli  antibodies,  which  produced 
hemagglutination in titers of 1:160 and  1:320 of rabbit cells modified by the 
homologous antigen.  Rabbit  red  cells  treated  with  the  heterologous  antigen 
were not agglutinated in these dilutions of serum. The antibody response was 
of a  low order; it is likely,  however, that a  larger number of injections may 
engender  antibodies  in  higher  titer.  Essentially  the  same  results  were  ob- 
tained in two additional rabbits following injection of rabbit blood cells modi- 
fied  by  a  boiled  E.  coli  broth  culture  filtrate.  The  filtrate  itself,  following 
three  intravenous  injections,  engendered  agglutinins  in  high  titer  (1:1600 
to 1:6400),  as measured by the hemagglutination  test. 
DISCUSSION 
It is an established  fact that certain viruses and  bacteria agglutinate red blood 
cells;  this phenomenon may be referred to as direct bacterial or viral bemagglutina- 
tion.  Moreover, antigens of some microorganisms, including viruses,  protozoa, and 12  HEM.AGGLUTINATION  AND  HEMOLYSIS  BY  ESCHERICHIA  COLI 
bacteria,  may be adsorbed onto red blood ceils and thus render them agglutinable 
by the antimicrobial  antibody, reactions,  which may be referred  to as indirect  or 
conditioned (26) microbial hemagglutination  and hemolysis. 
Keogh, North, and Warburton (20, 21)" were the first to demonstrate this indirect 
bacterial  hemagglutination.  Since then,  the following species or types of bacteria 
have been found capable of modifying red blood cells for agglutination or hemolysis by 
antibacterial  antibodies. 
Cocci:-- 
Micrococcus pyogenes (20, 24) 
Streptococcus pyogenes (20, 27) 
Diplococcus pneumoniae (20, 24) 
Neisseria raeningitidis (20) 
B ACI  LLI :-- 
Hemophilus pertussis (28, 29) 
Hemophibus influenzae type b (20, 30) 
salmonellae (20) 
Sd,  nondM typhesa (Vi antigen) (31) 
Skigdla sonne$ (24) 
gscherickia coli (23, 24, 19) 
Bacterium tularense (25) 
Pasteurella pestls (32) 
Corynebacterium diphtheriae (miffs type) (24) 
Mycobacterium tuberculosis ((22) and others) 
The experiments described in this communication revealed that the hemag- 
glutination and hemolysis tests can be  used successfully for the demonstra- 
tion of antibodies  active  against E.  coli  Olll  and  055  or  the homologous 
antigens.  The  group-specific rabbit  immune sera  produced agglutination of 
red cells  of a  variety of animal species which had adsorbed the homologous 
g. coli antigen. The hemagglutinin titer of these antisera is of the same order 
of magnitude as that yielding bacterial agglutination. However, when sheep 
ceils  were  treated with E.  coli  antigen,  hemolysis occurred  in  the presence 
of complement and antiserum in titers  far higher than those yielding agglu- 
tination of the bacteria  or of the modified red blood cells.  With  these new 
procedures available it is now possible  to reinvestigate the important question 
regarding the  antibody response  of infants suffering from diarrheal  disease 
associated with the presence of these serogroups of E. coli.  Such a study is of 
obvious interest, since in a  fair number of  such patients it was hitherto im- 
possible by means of the bacterial  agglutination test to demonstrate group- 
specific  antibodies and since the finding of such antibodies in increasing titer 
during the course of the disease would add further evidence to the concept of 
the etiological role of these microorganisms in epidemic and sporadic diarrheal 
disease of infants. Indeed, preliminary observations indicate that it is possible 
with the aid of the indirect hemagglutination test to demonstrate antibodies NETER,  BERTRAM, ZAK, MIYRDOCK, AND  ARBESM_AN  13 
against E.  coli,  serogroups  Olll  and/or 055,  in human sera,  which fail to 
agglutinate the homologous bacterial suspensions (Neter and Gorzynski, un- 
published data). It is now necessary to determine the titer of "normal" anti- 
bodies against E. coli Olll and 055 in human sera in relation to age, health, 
and past maladies of the individuals. It also remains to be determined whether 
the hemolysis test, which is extraordinarily sensitive with a system consisting 
of guinea pig complement and antibodies produced by rabbits,  can be used 
or so modified as to be equally as sensitive for the demonstration of human 
antibodies. In this connection it may be noted that complement of different 
animal species is not uniformly effective in all hemolytic systems and  that 
hemolysis depends,  in  addition  to  the  specificity of  antigen and  antibody, 
upon the sources of red blood cells, complement, and antibody (of. Rice (33)). 
It has been shown in the experiments reported here that the antigens char- 
acteristic of E. coli Olll and 055  can be demonstrated by means of hemag- 
glutination and  hemolysis inhibition tests.  These  procedures  may prove  to 
be  useful  in  studies  on  the  isolation  and  purification of  the  group-specific 
E.  coli antigens and in studies on the presence of soluble antigen in clinical 
material, such as fecal specimens. 
Regarding the question of the types of  antigens operative  in  hemaggluti- 
nation, hemolysis, and hemagglutination and hemolysis inhibition tests, the fol- 
lowing facts should be  kept  in mind. It  was established by Kauffmann (1) 
that these serogroups of E. coli contain, in addition to flagellar H  antigens, 
heatstable, somatic O  antigens, and heat-labile, envelope B  antigens.  Sero- 
group Olll  contains the B4 antigen and sero-group 055 the B5  antigen.  The 
B  antigens are responsible for O inagglutinability of  unheated bacterial sus- 
pensions; boiling inactivates the B  antigen and thus makes O  agglutination 
possible.  However, the antibody-binding property of the B  antigens is ther- 
mostable. Thus far strains of E. coli Olll and 055 lacking the B antigen have 
not been found, and it has not yet been possible to prepare pure B4 and B5 
antisera  (1).  All the axperiments reported above gave identical results with 
antisera containing O and B antibodies (sera obtained from rabbits immunized 
with unheated suspensions of bacteria)  as well as with antisera which  pre- 
sumably contained only O antibodies (sera of rabbits immunized with boiled 
suspensions of organisms or boiled broth culture filtrates). Therefore it may 
be  tentatively concluded that  the  above described tests are based  on a  re- 
action between the O antigen and the homologous antibody. Furthermore, it 
was shown that injection into rabbits  of rabbit red blood cells  treated with 
boiled cultures of either E.  coli Olll or 055 elicited the formation of group- 
specific E. coli antibodies; if, indeed, the B antigen is thermolabile, as stated 
by  Kauffmann  (1),  the  antibodies  thus  produced  cannot  be  B  antibodies. 
When pure B4 and.B5 antisera become available, it will be possible to determine 
whether  these antigens, too, can  be  demonstrated by means of hemaggluti- 14  HEMAGGLUTINATION AND  HEMOLYSIS  BY  ESCHERICHIA  COLI 
nation and hemolysis tests. It is of interest to note that only boiled antigens 
were found to be highly active in modifying red blood  cells for agglutination 
by the group-specific E. coli antisera. On  the other hand, the unheated ma- 
terials  do  contain antigen which  specifically inhibits  hemagglutination and 
hemolysis. It remains  to be elucidated whether boiling renders  the O antigen 
capable  of adsorption on red blood  cells through the inactivation of the B 
antigen or by means of other mechanisms. 
SUMMARy 
A study on hemagglutination and hemolysis by Esckerichia coli Olll and 
055  (rabbit)  antisera and on hemagglutination and hemolysis inhibition by 
E. coli Olll and 055 antigens revealed the following facts. 
1.  Red blood cells of man, dog, rabbit, guinea pig, sheep, rat, and chicken 
adsorb  E. coli Olll and 055 antigens and thus become  specifically aggluti- 
nable by the homologous E. coli antisera. 
2.  The adsorption of these E. coli antigens is a function of the concentration 
of the antigen, the time (from 5 minutes to 2 hours)  of treatment of the red 
blood cells with the antigen, and the concentration of the red blood cells used. 
3.  Red blood cells of man and sheep adsorb  simultaneously both antigens, 
as indicated by the fact that both antisera give agglutination of all red blood 
cells.  Complete  agglutination does  not occur  when a  mixture of red  blood 
cells treated separately with the two antigens is added to one or the other of 
the two antisera. 
4.  Treatment of red blood cells of man with one of the antigens does not 
block the adsorption of the second antigen. Human cells treated with either 
or both antigens are still  agglutinated by the homologous blood  group  (A, 
B, and Rh)-specific antibodies. 
5.  In the presence of guinea pig complement, E. coli Olll and 055 antisera 
produce  hemolysis  of modified human red blood  cells in titers of the same 
order  of magnitude as those giving  hemagglutination and  bacterial  aggluti- 
nation. The same  antisera produce hemolysis of sheep  cells treated with the 
identical  antigens  in  titers  exceeding  by far  those  giving  agglutination of 
modified human or sheep red blood cells. 
6.  Both sediment and supernate of a boiled E. coli suspension are capable 
of modifying red  blood  cells for E.  coli  hemagglutination; in  contrast,  the 
supernate obtained from an unhoiled  suspension  and then heated does not 
modify red blood cells for hemagglutination, although it contains the antigen 
which  can specifically adsorb  E.  coli antibodies,  as shown by means of the 
hemagglutination and hemolysis  inhibition tests. 
7.  Both the unheated and the boiled suspensions of E. coli Olll and 055 
inhibit  hemagglutination and  hemolysis  specifically. NETER, BERTRAM, ZAK, MURDOCK~ AND ARBESMAN  15 
8.  Rabbit red blood cells modified by either E. coli Olll  or 055 antigens, 
upon intravenous  injection  into  rabbits,  engender  specific E. coli  antibodies. 
The significance of the results is discussed. 
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